153 results
Page 3 of 8
8-K
8smeqtii n4amvq6mq
26 May 22
Regulation FD Disclosure
5:10pm
8-K
EX-99.1
durqqdpo9614pnu
26 May 22
Regulation FD Disclosure
5:10pm
8-K
EX-99.1
8yp9n s6h30e
12 May 22
Adicet Reports First Quarter 2022 Financial Results and Provides Business Updates
4:18pm
8-K
EX-99.1
2u69c1z3
5 May 22
Regulation FD Disclosure
7:03am
8-K
EX-99.1
scuko
19 Apr 22
Adicet Bio Receives FDA Fast Track Designation for Lead Candidate ADI-001
7:02am
8-K
EX-99.1
fovh4hdz5ilp4 09sr
15 Mar 22
Adicet Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress
4:10pm
8-K
usyx5
3 Feb 22
Other Events
7:00am
424B5
v39cxcbnqr9aox
9 Dec 21
Prospectus supplement for primary offering
5:14pm
424B5
mwx9of1
7 Dec 21
Prospectus supplement for primary offering
4:34pm
8-K
eoes7jy2d bi8ud1f
6 Dec 21
Other Events
7:55am
8-K
EX-99.1
pfxqsp 8z4vqkjg
12 Nov 21
Adicet Presents Preclinical Data for ADI-002, a GPC3-Targeted Development Candidate for Solid Tumors, at the SITC Annual Meeting
7:18am
8-K
l4xtg 9h5mn
12 Nov 21
Adicet Presents Preclinical Data for ADI-002, a GPC3-Targeted Development Candidate for Solid Tumors, at the SITC Annual Meeting
7:18am
8-K
EX-99.1
0eucu9
10 Nov 21
Adicet Reports Third Quarter 2021 Financial Results and Provides Business Updates
4:12pm
8-K
EX-99.1
op88vq557im0v0fa
13 Sep 21
Regulation FD Disclosure
8:14am
8-K
3ulzc5tn2u
13 Sep 21
Regulation FD Disclosure
8:14am